This treatment strategy has a number of benefits, including immediate alleviation of patient symptoms, avoidance of antiarrhythmic and anticoagulative therapy, and prevention of electrophysiologic remodeling, which is thought to contribute to the perpetuation of the arrhythmia. 1 Initial pharmacologic cardioversion is frequently attempted, and electrical cardioversion is reserved for patients with hemodynamic symptoms or in whom pharmacologic cardioversion has been unsuccessful. For the latter cases, pretreatment with ibutilide given immediately before transthoracic electrical cardioversion has been reported to enhance the rate of conversion to sinus rhythm. 2 We suggest that the use of propofol for sedation before electrical cardioversion can also improve the rate of successful cardioversion.
